COMPANY LIST

Business Expansion
on Kobe's Port Island

366

companies

as of November 30, 2019

KOBE Life Science
Cluster Company List

Companies listed in this brochure are participants of the Kobe Medical Industry Development Project and operating on Kobe Port Island. Companies are divided into each categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the miner field.

Search by Company name & Keyword

  • Business
  • Location
  • Initial

HEALIOS K.K.

Major field:Regenerative medicine

Research, development, manufacture of cell therapy products and regenerative medicine products

Overview

Raising our mission, “To be the change in an ever evolving world through enrichment of living”, HEALIOS was established in 2011 via Riken Venture system.
We are dedicated to develop promising medicines to heal and bring hope to those worldwide who are suffering from incurable diseases by making use of the regenerative power.

Product / Service / PR

    [Somatic stem cell regenerative medicine]
    Development of regenerative medicine for ischemic stroke and Acute Respiratory Distress Sydrome (ARDS) in Japan using MultiStem®, products developed by Athersys, Inc.
    [iPSC regenerative medicine]
    Development of Treatments for Age-Related Macular Degeneration (AMD) involving transplantation of iPS cell-derived retinal pigment epithelial (RPE) cells.
    Development of Organ Bud Transplantation Therapy involving a technology to create functional human organs using iPS cells.
Address: Kobe KIMEC Center Building 3F, 1-5-2 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan 
Web site: https://www.healios.co.jp/en/ E-mail: info@healios.jp

Hirosaki Life science Innovation, Inc.

Major field:Regenerative medicine

Miner field:Drug discovery

Development, manufacturing, and marketing of regenerative medicine products

Overview

Development, manufacturing and supply of regenerative and other medical products

Product / Service / PR

    Based on the results of an investigator-led clinical trial conducted by Kobe University and Foundation for Biomedical Research and Innovation (FBRI), Hirosaki Life science Innovation, Inc. is preparing for the pivotal clinical trial of IK-01, which is a collagen matrix containing chondrocytes indicated for focal articular cartilage defects in the knee, to obtain the marketing authorization.
Address: Kojimachi 285 Building 2F, Kojimachi 2-8-5,Chiyodaku Tokyo, 102-0083 Japan  (Contact Person Youichiro Machida)
TEL: +81-36-457-9861 FAX: +81-36-261-4445
Web site: http://hirosaki-li.co.jp/company.html E-mail: y-machida@hirosaki-li.co.jp

KCell, Inc.

Major field:CRO

Miner field:Regenerative medicine

Tecnical consulrtation and Engineering development for Cell manufacturing industrialization

Overview

There are many problems to be solved before cell production becomes an industry. To achieve this goal, KCell is focusing on:
-R&D on manufacturing cell products and therapy
-conducting contracted research
-technical consultation

Product / Service / PR

    KCell is devoted to development of system and software for future generation of cell manufacturing, which guarantees quality of the products and save cost for all production.
Address: TRI 3F, 1-5-4 Minatojima-minamimachi, Chuo-ku, Kobe, 650-0047 Japan  (Contact Person Yasuhiro Yanagi)
TEL: +81-78-335-5691
E-mail: kcell_lab@kcellinc.com

Sumitomo Dainippon Pharma Co., Ltd. Regenerative & Cellular Medicine Kobe Center

Major field:Drug discovery

Miner field:Regenerative medicine

Research of regenerative medicine and cell therapy

Overview

The Sumitomo Dainippon Pharma Group sets the pharmaceutical business as its core activity but also deploys other operations covering food ingredients, food additives and chemical product materials, animal health products, diagnostics and research materials.
In order to deliver innovative and useful pharmaceuticals to people worldwide as well as in Japan we make every effort in applying advanced R&D to all of our new pharmaceuticals. Aiming at improving customer satisfaction we also provide all relevant information with regard to our drug products.

Product / Service / PR

    We position the Regenerative Cellular medicine area in addition to the Psychiatry & Neurology and the Oncology areas as our focus therapeutic areas where we are targeting the creation of innovative pharmaceuticals.
    Here at Regenerative & Cellular Medicine Kobe Center, we are focusing on development research and manufacturing study of the cellular medicines those are derived from human iPS cells.
Address: Kobe KIMEC Center Building 5th Fl. 5-2, Minatojimaminamimachi 1-chome, Chuo-ku, Kobe,Hyogo 650-0047,Japan  (Contact Person Akiyoshi Kishino)
TEL: +81-078-306-2170 FAX: +81-078-303-4040
Web site: http://www.ds-pharma.com/ E-mail: https://www.ds-pharma.com/inquiry/

Tokyo Electron Ltd.

Major field:Regenerative medicine

Miner field:Drug discovery

Research for standardization of pluripotent stem cells to put cell therapy into practical use